Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 26,197,969 |
|
|||||
| News | - | ||||||
| Day High | 0.212 | Low High |
|||||
| Day Low | 0.1671 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Kintara Therapeutics Inc | KTRA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0555 | 33.04% | 0.2235 | 18:59:59 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.19 | 0.1671 | 0.212 | 0.1879 | 0.168 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 18,672 | 26,197,969 | US$ 0.1855112 | US$ 4,860,017 | - | 0.081 - 5.60 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:59:59 | formt | 250 | US$ 0.2235 | USD |
Kintara Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.42M | 39.04M | - | 0 | -15.02M | -0.38 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kintara Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KTRA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.16 | 0.212 | 0.15 | 0.1728115 | 10,869,060 | 0.0635 | 39.69% |
| 1 Month | 0.1618 | 0.212 | 0.125 | 0.1610107 | 8,626,271 | 0.0617 | 38.13% |
| 3 Months | 0.0987 | 0.24 | 0.081 | 0.1416988 | 13,934,371 | 0.1248 | 126.44% |
| 6 Months | 0.3656 | 0.4961 | 0.081 | 0.1410766 | 11,545,046 | -0.1421 | -38.87% |
| 1 Year | 3.04 | 5.60 | 0.081 | 0.176391 | 5,875,446 | -2.82 | -92.65% |
| 3 Years | 85.50 | 142.50 | 0.081 | 8.12 | 2,955,909 | -85.28 | -99.74% |
| 5 Years | 60.50 | 167.50 | 0.081 | 13.50 | 2,507,178 | -60.28 | -99.63% |
Kintara Therapeutics Description
| Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including the central nervous system, ovarian, and other solid tumors. The company is also advancing its proprietary late stage photodynamic therapy (PDT) platform that holds promise as a localized cutaneous or visceral tumor treatment as well as in other potential indications. |
